JP2010527915A5 - - Google Patents

Download PDF

Info

Publication number
JP2010527915A5
JP2010527915A5 JP2010506273A JP2010506273A JP2010527915A5 JP 2010527915 A5 JP2010527915 A5 JP 2010527915A5 JP 2010506273 A JP2010506273 A JP 2010506273A JP 2010506273 A JP2010506273 A JP 2010506273A JP 2010527915 A5 JP2010527915 A5 JP 2010527915A5
Authority
JP
Japan
Prior art keywords
alkyl
ring atom
ring
aryl
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2010506273A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010527915A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/005331 external-priority patent/WO2008133975A1/en
Publication of JP2010527915A publication Critical patent/JP2010527915A/ja
Publication of JP2010527915A5 publication Critical patent/JP2010527915A5/ja
Withdrawn legal-status Critical Current

Links

JP2010506273A 2007-04-26 2008-04-25 多重環化合物及びその用途 Withdrawn JP2010527915A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92628907P 2007-04-26 2007-04-26
PCT/US2008/005331 WO2008133975A1 (en) 2007-04-26 2008-04-25 Multi-ring compounds and uses thereof

Publications (2)

Publication Number Publication Date
JP2010527915A JP2010527915A (ja) 2010-08-19
JP2010527915A5 true JP2010527915A5 (enExample) 2012-07-05

Family

ID=39925991

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010506273A Withdrawn JP2010527915A (ja) 2007-04-26 2008-04-25 多重環化合物及びその用途

Country Status (5)

Country Link
US (1) US20100249111A1 (enExample)
EP (1) EP2141994A4 (enExample)
JP (1) JP2010527915A (enExample)
CA (1) CA2685029A1 (enExample)
WO (1) WO2008133975A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8012955B2 (en) 2006-12-28 2011-09-06 Rigel Pharmaceuticals, Inc. N-substituted-heterocycloalkyloxybenzamide compounds and methods of use
NZ585298A (en) * 2007-11-16 2012-08-31 Rigel Pharmaceuticals Inc Carboxamide, sulfonamide and amine compounds for metabolic disorders
EP2231666B1 (en) 2007-12-12 2015-07-29 Rigel Pharmaceuticals, Inc. Carboxamide, sulfonamide and amine compounds for metabolic disorders
EP2276735A1 (en) * 2008-04-17 2011-01-26 Pfizer Inc. Ether benzylidene piperidine aryl carboxamide compounds useful as faah inhibitors
CA2717087A1 (en) * 2008-04-17 2009-10-22 Pfizer Inc. 4-[3-(aryloxy)benzylidene]-3-methyl piperidine 5-membered aryl carboxamides
WO2009127943A1 (en) * 2008-04-17 2009-10-22 Pfizer Inc. Ether benzylidene piperidine 5-membered aryl carboxamide compounds useful as faah inhibitors
US20110053950A1 (en) * 2008-04-17 2011-03-03 Pfizer, Inc. 4-benzylidene-3-methylpiperidine aryl carboxamide compounds useful as faah inhibitors
US20110053949A1 (en) * 2008-04-17 2011-03-03 Pfizer Inc. 4-[3-(aryloxy)benzylidene]-3-methyl piperidine aryl carboxamide compounds useful as faah inhibitors
BRPI0911681B8 (pt) 2008-04-23 2021-05-25 Rigel Pharmaceuticals Inc composto, composição farmacêutica, e, método para ativar a via de proteína quinase ativada por 5'-amp em uma célula in vitro
WO2012033069A1 (ja) * 2010-09-07 2012-03-15 大鵬薬品工業株式会社 プロスタグランジンd合成酵素を阻害するピペリジン化合物
UY36391A (es) 2014-11-05 2016-06-01 Flexus Biosciences Inc Compuestos moduladores de la enzima indolamina 2,3-dioxigenasa (ido1), sus métodos de síntesis y composiciones farmacèuticas que las contienen
CA3121202A1 (en) 2018-11-30 2020-06-04 Nuvation Bio Inc. Pyrrole and pyrazole compounds and methods of use thereof

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3577415A (en) * 1968-12-23 1971-05-04 Robins Co Inc A H 1-substituted-3-substituted phenoxypyrrolidines
US4263438A (en) * 1977-09-13 1981-04-21 Pfizer Inc. 3-[2,4-(Disubstituted)-phenyl]azacycloalkanones as analgesics
US4452809A (en) * 1980-03-10 1984-06-05 A. H. Robins Company, Inc. Trans-4-(2-chlorophenoxy)-1-ethyl-3-pyrrolidinol and anti-depressant use thereof
WO1992018475A2 (en) * 1991-04-17 1992-10-29 The Upjohn Company Substituted phenylazacycloalkanes as cns agents
US5519134A (en) * 1994-01-11 1996-05-21 Isis Pharmaceuticals, Inc. Pyrrolidine-containing monomers and oligomers
US6313127B1 (en) * 1996-02-02 2001-11-06 Zeneca Limited Heterocyclic compounds useful as pharmaceutical agents
HRP970371A2 (en) * 1996-07-13 1998-08-31 Kathryn Jane Smith Heterocyclic compounds
US6022884A (en) * 1997-11-07 2000-02-08 Amgen Inc. Substituted pyridine compounds and methods of use
AR033517A1 (es) * 2000-04-08 2003-12-26 Astrazeneca Ab Derivados de piperidina, proceso para su preparacion y uso de estos derivados en la fabricacion de medicamentos
AUPR362001A0 (en) * 2001-03-08 2001-04-05 Fujisawa Pharmaceutical Co., Ltd. New compound
DE10217006A1 (de) * 2002-04-16 2003-11-06 Merck Patent Gmbh Substituierte Indole
ES2253691T3 (es) * 2002-07-24 2006-06-01 Eli Lilly And Company Modulares selectivos del receptor de estrogeno basados en dihidrodibenzo(b,e)oxepina, composiciones y procedimientos.
SE0300456D0 (sv) * 2003-02-19 2003-02-19 Astrazeneca Ab Novel compounds
SE0301368D0 (sv) * 2003-05-09 2003-05-09 Astrazeneca Ab Chemical compounds
US20060019256A1 (en) * 2003-06-09 2006-01-26 The Regents Of The University Of Michigan Compositions and methods for treating and diagnosing cancer
US7094791B2 (en) * 2003-07-31 2006-08-22 Avalon Pharmaceuticals, Inc. Derivatives of 3-hydroxy-pyrrole-2,4-dicarboxylic acid and uses thereof
CA2539361A1 (en) * 2003-09-19 2005-03-31 Pfizer Products Inc. Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and an estrogen agonist/antagonist
US7683059B2 (en) * 2003-10-28 2010-03-23 Amgen Inc. Triazole compounds and uses related thereto
BRPI0417156A (pt) * 2003-12-12 2007-03-06 Lilly Co Eli composto, composição farmacêutica, e, métodos para bloquear receptor mu, capa, delta ou combinação (heterodìmero) dos mesmos em mamìferos, para tratar e/ou prevenir doenças relacionadas com obesidade e obesidade, para suprimir apetite em um paciente, para efetuar perda de peso em um paciente obeso
EP1710233A4 (en) * 2004-01-28 2009-07-15 Kissei Pharmaceutical NEW BENZO FURANDERIVATE, THIS MEDICAL COMPOSITION AND APPLICATIONS THEREOF
CN101812056A (zh) * 2004-06-18 2010-08-25 神经研究公司 作为单胺神经递质再摄取抑制剂的新颖烷基取代的哌啶衍生物
MY179032A (en) * 2004-10-25 2020-10-26 Cancer Research Tech Ltd Ortho-condensed pyridine and pyrimidine derivatives (e.g.purines) as protein kinase inhibitors
DE602005019316D1 (en) * 2004-11-24 2010-03-25 Lilly Co Eli Aromatische etherderivate als thrombin-hemmer
AP2007004047A0 (en) * 2005-01-20 2007-06-30 Pfizer Ltd Substituted triazole derivatives as oxtocin antagonists
FR2884516B1 (fr) * 2005-04-15 2007-06-22 Cerep Sa Antagonistes npy, preparation et utilisations
TW200738676A (en) * 2005-06-20 2007-10-16 Schering Corp Heteroatom-linked substituted piperidines and derivatives thereof useful as histamine H3 antagonists
WO2007098086A2 (en) * 2006-02-17 2007-08-30 Avalon Pharmaceuticals Hydroxypiperidine derivatives and uses thereof

Similar Documents

Publication Publication Date Title
JP2010527915A5 (enExample)
RU2500680C2 (ru) Новые замещенные пиридин-2-оны и пиридазин-3-оны
PH12012501773A1 (en) Arylethynyl derivatives
EA201490722A1 (ru) ПРОИЗВОДНЫЕ ЭТИНИЛА В КАЧЕСТВЕ АЛЛОСТЕРИЧЕСКИХ МОДУЛЯТОРОВ МЕТАБОТРОПНОГО РЕЦЕПТОРА ГЛУТАМАТА mGluR5
RU2012108629A (ru) Фенилэтинильные производные в качестве ингибиторов вируса гепатита с
WO2008101935A3 (fr) Nouveaux composés dérivés d'indole et compositions pharmaceutiques les contenant
AR060623A1 (es) Compuestos derivados de 2-azetidinona y un metodo de preparacion
RU2010116253A (ru) Производные n-гидроксилсульфонамида как новые физиологически применимые доноры нитроксила
JP2010528089A5 (enExample)
WO2008115098A3 (fr) 2,3,4,5-tétrahydro-1h-pyrido[4,3-b]indoles substitués ainsi que procédés de leur fabrication et leur utilisation
WO2008108386A1 (ja) 医薬組成物
ATE380818T1 (de) Piperazine-substituierte aryl-benzodiazepinen und ihre verwendung als dopaminrezeptor-antagonisten zur behandlung von psychose
CY1116865T1 (el) Παραγωγα υποκατεστημενης διβενζο-αζεπινης και βενζο-διαζεπινης χρησιμα ως αναστολεις της γαμμα-σεκρετασης
AR078163A1 (es) Utilizacion de aminodihidrotiazinas para el tratamiento o prevencion de la diabetes
EA201101089A1 (ru) Производные оксадиазола в качестве агонистов рецептора s1p1
NO20080738L (no) Fremgangsmater for neurobeskyttelse
AR081426A1 (es) Derivados de pirazol inhibidores del receptor sigma
RU2012141889A (ru) Производные кетобензофурана, способ их синтеза и промежуточные соединения
AR039698A1 (es) Agonistas de los receptores cannabinoides
CR10034A (es) Derivados de oxadiazol
MX2009003927A (es) Derivado espirocetal de tioglucosa y uso del mismo como un agente terapeutico para la diabetes.
RU2010115337A (ru) Трициклические гетероциклические производные
HRP20151439T1 (hr) Halogenirani derivati benzamida
MX2013002557A (es) Nuevos analogos de piperazina como antivirales de influenza de amplio espectro.
CY1117212T1 (el) Εθυνυλο παραγωγα ως μεταβοτροπικοι ρυθμιστες του υποδοχεα γλουταμινικου